ENMEDIA explores the DeSci movement’s potential to dismantle barriers and foster a new era of innovation.
Blockchain technology was once a niche interest among tech enthusiasts. But since it hit the mainstream consciousness in the early 2010’s it has continued to garner attention from diverse corners – speculators, techies, people all across the political spectrum and of course, regulators. Blockchain underpins not just cryptocurrencies like the well-known Bitcoin and Ethereum, but increasingly a wide array of applications from supply chain management to secure voting systems. Multi-trillion-dollar asset manager Blackrock recently made headlines with its entry into the space.
At its core, blockchain provides a decentralized ledger, ensuring data integrity through a network consensus rather than a central authority. Although it has plenty of skeptics, this architecture promises transparency and immutability; once data is encoded, altering it without network consensus is virtually impossible, as long as the chain boasts strong security via a diversified and robust network of transaction validators or “miners.”
And now, blockchain has made its way into the realm of scientific research through the Decentralized Science (DeSci) movement. By now you’ve likely heard of its cousin, decentralized finance or “DeFi.” Just as DeFi looks to disintermediate financial services, DeSci hopes to remodel the landscape of scientific research, publishing, and funding, addressing systemic barriers that have long stifled innovation. At the forefront of DeSci is the promise to dismantle the paywalls that have restricted access to scientific knowledge, positioning scientific discovery as a public good accessible to all.
These types of projects are often organized under a structure called a DAO (decentralized autonomous organization). A DAO is an entity that operates through the use of smart contracts on a blockchain. These rules-based contracts automate organizational governance, allowing DAOs to operate without centralized control. Members typically govern the DAO collectively, making decisions through a consensus mechanism, commonly involving token-based voting.
Tokens can be listed on exchanges (both centralized and decentralized), resulting in a market mechanism where anybody can buy and sell the tokens. If you’re optimistic on the potential of a project, you can buy and hold the token, anticipating it will rise in value as the project grows.
The enthusiasm for DeSci is tempered by some inherent challenges. Questions arise around maintaining the rigor and integrity of scientific research when traditional peer review mechanisms are replaced by community-driven evaluations and token-based incentives. Could the allure of commercial gains skew the focus away from foundational science?
The advent of blockchain applications has led to an explosion of tokens and cryptocurrencies, each competing for investor attention and market liquidity. For a project to thrive, it may need to attract enough trading volume to ensure liquidity while also demonstrating clear value and utility beyond speculation. The emergence of new tokens can dilute investment from existing projects, potentially undermining their development and stability.
Balancing innovation with scientific integrity is key. But whatever the potential drawbacks, movements like DeSci do have one significant edge: impeccable timing. They’re coming along at a time when trust in traditional institutions is eroding at an alarming rate.
Some notable DeSci projects:
- LabDAO: An online collective enhancing computational life science research with open-source tools, including BioML models, for global collaboration.
- AxonDAO: Utilizes blockchain and AI to revolutionize healthcare data, evolving from a telemedicine startup to a DAO focused on transparent, patient-centric care.
- Rejuve.AI: Targets aging research through advanced AI, analyzing network data to offer breakthrough insights, aiming for accessible and affordable outcomes.
- VitaDAO: A community-driven collective funding longevity science, with over $4.2 million invested in 22 research projects to combat age-related diseases.
Disclaimer: This article is for informational purposes only and should not be considered as financial advice.